The use of EHF therapy is due to the immunostimulating, regenerative effect of EHF waves, as well as their ability to relieve pain.
In endometrial hyperplasia (glandular, glandular-cystic endometrial hyperplasia, endometrial polyposis, adenomyosis), both mono-EHF therapy and combined with medication (in particular, hormonal) are used.
Used HF emitters
- Frequency 40-43 GHz, wavelength 7.1 mm (red).
- Noise-frequency 52-78 GHz (yellow).
Monotherapy-10 procedures for 20 min. from 8-10 to 20-22 days of the cycle.
Combined with hormonal — 10 procedures for 30 min. from 8-10 to 20-22 days of the cycle, hormone therapy is prescribed, starting with the next menstrual cycle for 6 months. In three months — a second course of EHF therapy.
Impact ZONE: the area of the sternum at the level of the second rib.
Clinical effect and control
Improvement of the General condition, relief of pain syndrome, when combined with hormone therapy, the normalization of hormonal indicators occurs. Stimulation of the immune system is manifested mainly in the T-lymphocytic system (absence of t-lymphocyte depression). In addition, the number of circulating immune complexes and the number of neutrophils that form spontaneous rosettes increases. Control is carried out by ultrasound of the uterus, laboratory tests and the state of cellular immunity.
Absolute contraindications have not been identified. Relative contraindications — pregnancy, uterine hemorrhage (see contraindications in the General EHF-therapy).
p/s Our English is not perfect . We will be happy if you point out transcription errors in comments. And you can write your questions also about this treatment protocol.